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Abstract
Background: Synaptic genes, NLGN3 and NLGN4X, two homologous members of the neuroligin family, have been
supposed as predisposition loci for autism spectrum disorders (ASDs), and defects of these two genes have been
identified in a small fraction of individuals with ASDs. But no such rare variant in these two genes has as yet been
adequately replicated in Chinese population and no common variant has been further investigated to be
associated with ASDs.
Methods: 7 known ASDs-related rare variants in NLGN3 and NLGN4X genes were screened for replication of the
initial findings and 12 intronic tagging single nucleotide polymorphisms (SNPs) were genotyped for case-control
association analysis in a total of 229 ASDs cases and 184 control individuals in a Chinese Han cohort, using matrix-
assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.
Results: We found that a common intronic variant, SNP rs4844285 in NLGN3 gene, and a specific 3-marker
haplotype X
A-X
G-X
T (rs11795613-rs4844285-rs4844286) containing this individual SNP were associated with ASDs
and showed a male bias, even after correction for multiple testing (SNP allele: P = 0.048, haplotype:P = 0.032).
Simultaneously, none of these 7 known rare mutation of NLGN3 and NLGN4X genes was identified, neither in our
patients with ASDs nor controls, giving further evidence that these known rare variants might be not enriched in
Chinese Han cohort.
Conclusion: The present study provides initial evidence that a common variant in NLGN3 gene may play a role in
the etiology of ASDs among affected males in Chinese Han population, and further supports the hypothesis that
defect of synapse might involvement in the pathophysiology of ASDs.
Background
Autism spectrum disorders (ASDs; MIM 209850) are
acknowledged to be among the most heritable neurode-
velopmental disorders with onset prior to age 3, which
characterized by impaired reciprocal social interactions,
deficient communication, restricted interests and stereo-
typed activity patterns (American Psychiatric Associa-
tion, 2000). ASDs present a broadly defined disorders of
behavior and cognition, including autism, Asperger
syndrome and pervasive developmental disorder not
otherwise specified (PPD-NOS) [1], which were concep-
tualized as a spectrum of disorders occurring on a conti-
nuum with a great diversity of symptom and varying
degrees of severity. Asperger syndrome is diagnosed
when lacks delays in cognitive development and lan-
guage, and PDD-NOS is diagnosed when full criteria for
the other two disorders are not met [2].
It is now well established that ASDs are etiologically
heterogeneous, probably associated with a combination
of the effects of genetic and environmental causes [3-5].
The strong role of genetic factors in the pathogenesis of
ASDs has been definitely recognized, but still difficult
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ASDs cases are already identified to be attributable to
genetic syndromes with highly penetrant chromosomal
abnormalities, known rare mutations, and copy number
variants (CNVs) [1], but the causes of the majority of
ASDs cases remain further determined and the biological
basis remains pooly understood. Thus, neuroscience
research efforts have focused on elucidating the neuro-
biological basis of ASDs, and a growing body of evidence
indicates that ASDs are brain development disorders
occuring during prenatal and postnatal period, and to
put forward the possibility that the neuropathology of
ASDs may present an on-going process extending
through early childhood and into adulthood [6,7]. More-
over, histological studies on post-mortem brains have
also revealed that neurons from autistic patients exhibit a
reduction of GABA production, dendrite branching and
arborization. Considering the fact that the normal func-
tions of brain depend on proper working of the diverse
synaptic components distributed in various compart-
ments of the synapse, which is specialized site of cell-cell
contact allowing communication between neurons, the
synaptic hypothesis was proposed that abnormalities at
the synapse may contribute to development of brain dis-
orders such as ASDs and mental retardation. A genetics
topic in ASDs has emerged focusing on identification of
the synaptic genes contributing to the formation and
function of the synapse. The synaptic hypothesis was also
confirmed by the discovery of mutations in trans-synap-
tic adhesion proteins, such as neuroligins and neurexins,
in a small fraction of individuals with ASDs, which was
proposed to alter synaptic homeostasis and/or impair
synapse development [8,9].
It is striking that ASDs show markedly skewed in sex
distribution with approximately four times more frequent
in male than female, together with the view that some of
X-chromosomal genes may be involved in human neu-
ropsychiatric disorders (X-linked disorders) [10], specu-
lating that X chromosome may be of importance for the
development of this condition. Many independent gen-
ome-wide scans for ASDs susceptibility loci have also
demonstrated that X chromosome may contain more
than one ASDs susceptibility genes. Two X-linked neuro-
ligin genes, neuroligin 3 (NLGN3) and neuroligin 4X
(NLGN4X) were therefore considered as good functional
and positional candidate for predisposition to ASDs and
have been screened for mutations in multiple studies.
Neuroligins are cell adhesion molecules localized post-
synaptically in the glutamatergic synapses, and interact
with presynaptic neurexins [11] to form heterophilic
complex, which likely play an critical role in synaptic
transmission and differentiation of synaptic contacts
[12-14]. The role of neuroligins in ASDs was implicated
in discovery deletions of Xp22.1 containing the
NLGN4X gene in three autistic females [15]. Then
Jamain et al. [16] first demonstrated the evidence for a
pathogenic effect of neuroligins in ASDs, who identified
a missense mutation (R451C) in NLGN3 and a frame-
shift mutation (1186insT) in the homologous gene
NLGN4X in two Swedish families in each case one
brother with typical autism and the other with Asperger
Syndrome. The mutant proteins were considered signifi-
cantly retained in the endoplasmic reticulum with
reduced protein expression and/or adhesive activity to
impair their function in the synaptogenesis compared
with the wild-type neuroligin proteins [17,18]. Later, a
2-bp deletion (1253delAG) encoding a truncating
NLGN4X protein (D429X) was detected in all indivi-
duals affected with mental retardation within a large
French family [19], providing the evidence that rare
mutations of these two neuroligin genes seem to contri-
bute to developmental delay and ASDs. Animal model
studies showed that mice carrying the R451C mutation
of NLGN3 [20] or a deletion of NLGN4X [21] caused
an increase in inhibitory synaptic activity and exhibited
behavioral phenotypes characteristic of ASDs due to
protein misfolding [22], highlighting a possible role for
excess inhibitory neurotransmission in ASDs. In addi-
ton, the specific NLGN3 mutation has also been consid-
ered to affect information processing in neuronal
networks by altering network architecture and syn-
chrony in a recent report [23]. Afterward, further
genetic rare variants, including non-synonymous muta-
tions and splice variants, in the NLGN4X gene were
detected in probands with autism, mental retardation or
pervasive developmental disorders-not otherwise speci-
fied (PDD-NOS) in following replication studies [24-27].
In contrast, controversial results obtained from several
replication studies failing to detect neuroligin variants in
samples of individuals with ASDs from different popula-
tions [28-31]. Moreover, no evidence was found for
involvement of NLGN3 and NLGN4X with high-func-
tioning ASDs in a 2008 study [32]. These results indi-
cate that these rare mutations may be responsible for a
small fraction of events and should been widely repli-
cated and validated by other independent studies with
different genetic background.
Meanwhile, there is emerging evidence indicating that
the genetic etiology of complex traits of ASDs is likely to
be based on a combination of multiple rare and common
susceptibility loci. And common variants in susceptibility
genes are also of importance for majority individuals,
although exerting merely a modest or small effect sizes
contributing to the genetic background of diseases [33].
However, little such variants in NLGN3 and NLGN4X
gene have as yet been proven beyond doubt to be asso-
ciated with ASDs [34]. So it is important to search for
additional common variants for a better understanding of
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responsible for ASDs susceptibility.
In the present study, we therefore attempted to repli-
cate known rare variants in NLGN3 and NLGN4X genes
to validate the initial findings and determine their fre-
quencies in Chinese Han population, and further per-
formed a case-control association analysis of tagging
SNPs within these two neuroligin genes to evaluate if
common variants also play a potentially role for etiology
of ASDs.
Methods
Subjects
Subjects recruited in our study consisting of 229 unre-
lated patients with ASDs and 191 ethnically and geogra-
phically matched controls in Chinese Han cohort. All
affected subjects (mean age: 5.5 years, 83.4% males,
16.6% females) were from outpatients of Children’s Hos-
pital, Zhejiang University School of Medicine and from
several special autism-training schools, which were diag-
nosed using the diagnostic and statistical manual of
mental disorders (DSM-IV) criteria or International
Classification of Diseases-10 (ICD-10) by an experienced
psychiatrist. In the present study, a relatively homoge-
neous sample of ASDs with typical phenotype was taken
in to reduce heterogeneity. Clinical assessment and phy-
sical examination were obtained and the molecular tests
were performed to exclude the patients with fragile X
syndrome and tuberous sclerosis, or any kind of medical
conditions suspected to be associated with ASDs. The
controls (mean age: 3.2 years, 74.3% males, 25.7%
females) sharing the same ethnical background with the
affected subjects were unrelated Chinese individuals
who had visited our hospital to evaluate their health sta-
tus. They were clinically assessed to confirm the absence
of both personal and family history of major neuropsy-
chiatric disorders. The study was approved by Ethics
Committee of Zhejiang University and written informed
consents were obtained from parents or legal guardians
for their participating in the study.
Selection of rare mutations and SNPs
7 known rare variants in NLGN3 and NLGN4X genes
previously reported to be associated with ASDs were
chosen for rare variant screening (Table 1). The tagging
SNPs were selected based on pair-wise r
2 method (para-
meter: r
2 ≥ 0.8) using SNPbrowser software. Based on
the genotype data from the SNP databases http://www.
ncbi.nlm.nih.gov/snp/, 12 validated and suitable tagging
SNPs within NLGN3 and NLGN4X genes (Table 2) with
a minor allele frequency (MAF) greater than 5% in the
H a n _ C h i n e s eo ri nt h eH C B _ A s i a np o p u l a t i o nw e r e
selected to capture the majority of the common varia-
tions for case-control association analysis.
Rare Variants Screening and SNPs Genotyping
Genomic DNA was extracted from venous blood sample
using AXYGEN DNA extraction kit (AxyPrep Blood
Genomic DNA Miniprep Kit, USA), according to the
manufacture’s recommended protocol. Rare variant
screening and SNPs genotyping were performed using
matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry (Sequenom Inc., San
Diego, California) and analyzed with the SpectroTYPER
RT 2.0 software. A routine quality control procedure to
assess genotyping reproducibility was performed by
repeating 10% of samples selected randomly.
Statistic analysis
Considering highly varying prevalence in female and male
patients of ASDs, we separate subjects by gender into case
and control subgroups. The Hardy-Weinberg equilibrium
(HWE) for SNP markers on the X chromosome can be
examined by testing two null hypotheses: H1: allele fre-
quencies between males and females are equal and H2:
HWE holds in females [35]. A basic association of allele
frequencies was analyzed in PLINK version 1.07 software
(http://pngu.mgh.harvard.edu/purcell/plink/; Purcell et al,
2009) [36] and corrected by Bonferroni’sa p p r o a c hf o r
multiple testing as the most stringent test to control false-
positive results. The crude odds ratios (ORs) with 95%
confidence intervals (95% CIs) were estimated for the
effects of high-frequency allele in the case group. Pair-wise
linkage disequilibrium (LD) between the different markers
was estimated by the D’ and r
2, using Haploview version
4.2 software (http://www.broad.mit.edu/mpg/haploview
Barrett et al., 2005) [37] with visualized structure. Haplo-
type blocks within each gene were defined by the default
algorithm of Gabriel method [38] and haplotype frequen-
cies were estimated with the expectation maximization
(EM) algorithm, excluding haplotypes with frequencies
lower than 5%. While for X-linked SNP in male samples,
genotype of each SNP was interpreted as homozygous
(genotype X
AX
A or X
BX
B), although the male X was hemi-
zygous (genotype X
A or X
B). The exact P-values with
10,000 permutations were done for multiple test correc-
tion of the observed haplotype association. The differences
were considered statistically significant with P < 0.05.
Post-hoc power analysis was implemented using the com-
puter G*Power.
SNPs were removed from analysis if they had the per-
centage of non-missing genotypes less than 0.95, dis-
played Hardy-Weinberg disequilibrium (P < 0.05), or
had a minor allele frequency (MAF) < 0.05.
Results
Rare variants analysis
None of these 7 rare variants in NLGN3 and NLGN4X
genes previously known to associated with ASDs was
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trols (Table 1).
Single nucleotide polymorphisms (SNPs) analysis
The genotypic distribution displayed no deviation from
Hardy-Weinberg equilibrium (P > 0.05) (data not
shown). Allelic frequencies and association findings of
all these SNPs between patients with ASDs and controls
in primary and sex-specific analyses have been summar-
ized in Table 2. Pair-wise linkage disequilibrium (LD)
between SNPs within each gene was calculated for
males and females separately, and D’ and r
2 values for
all possible pairs were shown in Figure 1. Haplotype
blocks generated by the Gabriel method were also
shown in Figure 1. The results of the association analy-
sis based on haplotype for each gene were summarized
in Table 3.
As shown in Table 2, nominally significant differences
of allele frequencies were detected for three SNPs in
NLGN3 gene in total samples contrasted between indivi-
duals with ASDs and controls and these differences
remained significant after Bonferroni correction for mul-
tiple testing. Giving the higher prevalence rate of ASDs
in males than in females, we performed a secondary case-
control analysis across all of SNPs stratified by sex. The
sex-specific analysis showed that the significant differ-
ences of these three SNPs were almost entirely account
for association with affected males. While only one SNP
rs4844285 remained the evidence of significant associa-
tion after Bonferroni correction testing (Pcorr = 0.048)
and the rs4844285-X
G allele had an increased risk for
male with ASDs (OR = 1.872, 95% CI:1.175-2.981). Pair-
wise linkage disequilibrium (LD) revealed that the six
SNPs analyzed were in high LD (D’ > 0.8), and there were
one three-marker haplotype block in male subgroup and
two two-marker haplotype blocks in female subgroup
generated by the default algorithm of Gabriel method
(Figure 1). In male subgroup, a significant association
was observed for the three-marker haplotype block
(rs11795613-rs4844285-rs4844286, global P value =
0.032) containing the individual SNP rs4844285 asso-
ciated with male ASDs in the allelic-wise analysis. The
most frequent haplotype X
A-X
G-X
T was significantly
more frequent in male patients with ASDs when com-
pared to male controls (P = 0.009) and the diference
remained after permutation testing (Pper = 0.017), which
suggested that the haplotype X
A-X
G-X
T p l a yar o l ea sa
susceptibility factor for ASDs (OR = 1.834, 95% CI:
1.158-2.907). In female subgroup, one two-marker haplo-
type block (rs11795613-rs4844285) showed significant
association with ASDs (global P value = 0.035). The hap-
lotype X
A-X
G was significantly more frequent in patients
with ASDs compared with controls acting as a suscept-
ibility factor for ASDs (P = 0.035, OR = 2.147, 95%CI:
1.048-4.400), while the haplotype X
G-X
A was more fre-
quent in controls likely acting as a protective factor
against ASDs (P = 0.035, OR = 0.446, 95%CI: 0.227-
0.954). These results did not survive 10,000 times permu-
tation testing.
For NLGN4X gene, nominal significant difference in
allelic frequency of SNP rs5916397 was detected between
the female individuals with ASDs and controls (P = 0.047).
The rs5916397-X
A allele was overrepresented in female
individuals with ASDs (OR = 2.133, 95% CI = 1.001-4.545)
while this difference disappeared for Bonferroni correc-
tion. Although no haplotype block containing this SNP
was detected by the Gabriel method, this SNP was in rela-
tively high LD with rs6529901 (D’ > 0.8) and was available
for the multimarker analysis. The result showed that no
association was observed for this two-marker haplotype
(rs6529901-rs5916397) both in males and females (males:
global P value = 0.580, females: global P value = 0.145),
Table 1 Summary and results of previously known rare variants in NLGN3 and NLGN4X gene
Gene Sequence
variant
Amino-acid
change
Mutation type Position in
gene
Occurrence in ASDs/total
ASDs**
Occurrence in controls/total
controls**
NLGN3 c.C1351T R451C Missense
mutation
Exon 6 0/229 0/188
NLGN4X c.1186insT D396X Frameshift
mutation
Exon 5 0/227 0/190
c.1253delAG D429X Frameshift
mutation
Exon 5 0/229 0/190
c.759G > A G99S Missense
mutation
Exon 3 0/229 0/191
c.1597A > G K378R Missense
mutation
Exon 6 0/227 0/191
c.1671G > A V403M Missense
mutation
Exon 6 0/229 0/191
c.2574C > T R704C Missense
mutation
Exon 7 0/229 0/189
**due to uncertainties, some sites were miss-identified for several samples, even by repeating.
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Page 4 of 10Table 2 Allelic frequencies and case-control association analysis with ASDs in the primary and sex-specific analyses within the NLGN3 and NLGN4X genes
Total samples (N = 420) Male samples (N = 333) Female samples (N = 87)
Genes SNP Position
in gene
Assoc
Allele
Allele
counts in
controls
(%)
Allele
counts in
cases(%)
P
value
Pcorr
value
OR
(95%CI)
Allele
counts in
controls
(%)
Allele
counts in
cases(%)
P
value
Pcorr
value
OR
(95%
CI)
Allele
counts in
controls
(%)
Allele
counts in
cases(%)
P
value
Pcorr
value
OR
(95%
CI)
NLGN3 rs11795613
(G/A)
Intron1 X
A 150(62.5%) 199
(74.5%)
0.0035 0.021 1.756
(1.201-
2.567)
84 (59.2%) 137
(71.7%)
0.0163 ns 1.752
(1.106-
2.774)
66 (67.3%) 62(81.6%) 0.035 ns 2.147
(1.048-
4.4)
rs4844285
(A/G)
Intron2 X
G 149(62.6%) 201
(75.6%)
0.0016 0.0097 1.847
(1.259-
2.711)
83 (59.3%) 139
(73.2%)
0.0079 0.048 1.872
(1.175-
2.981)
66 (67.3%) 62(81.6%) 0.035 ns 2.147
(1.048-
4.4)
rs4844286
(G/T)
Intron2 X
T 163(67.9%) 206
(77.2%)
0.0196 ns 1.595
(1.076-
2.365)
95 (66.9%) 145
(75.9%)
0.07 ns 1.559
(0.963-
2.525)
68 (69.4%) 61(80.3%) 0.104 ns 1.794
(0.882-
3.648)
rs5981079
(C/T)
Intron2 X
T 132(55.5%) 175
(67.0%)
0.0079 0.047 1.634
(1.136-
2.35)
79 (55.6%) 126
(66.7%)
0.041 ns 1.595
(1.019-
2.497)
53 (55.2%) 49(68.1%) 0.092 ns 1.728
(0.913-
3.272)
rs7051529
(G/A)
Intron4 X
A 132(58.9%) 182
(68.7%)
0.025 ns 1.528
(1.054-
2.217)
73 (56.2%) 125
(65.4%)
0.093 ns 1.479
(0.936-
2.336)
59 (62.8%) 57(77.0%) 0.047 ns 1.989
(1.003-
3.943)
rs10127395
(G/T)
Intron5 X
T 196(81.7%) 221
(83.1%)
0.676 ns 1.102
(0.698-
1.743)
117(82.4%) 158
(83.2%)
0.855 ns 1.055
(0.594-
1.875)
79 (80.6%) 63(82.9%) 0.700 ns 1.166
(0.535-
2.541)
NLGN4X rs6529901
(G/A)
Intron3 X
A 129(55.8%) 150
(56.8%)
0.827 ns 1.04
(0.729-
1.485)
82 (58.2%) 104
(54.7%)
0.535 ns 0.87
(0.56-
1.351)
47 (52.2%) 46(62.2%) 0.201 ns 1.503
(0.804-
2.812)
rs5961397
(G/A)
Intron3 X
A 176(73.6%) 198
(74.2%)
0.895 ns 1.027
(0.69-
1.528)
106(75.2%) 134
(70.2%)
0.312 ns 0.776
(0.475-
1.27)
70 (71.4%) 64(84.2%) 0.047 ns 2.133
(1.001-
4.545)
rs4370667
(C/T)
Intron2 X
T 183(80.6%) 212
(80.0%)
0.864 ns 0.962
(0.616-
1.502)
112(81.8%) 150
(79.4%)
0.592 ns 0.859
(0.491-
1.501)
71 (78.9%) 62(81.6%) 0.665 ns 1.185
(0.549-
2.559)
rs10522049
(G/A)
Intron2 X
A 198(82.8%) 223
(83.5%)
0.839 ns 1.049
(0.658-
1.35)
114(80.9%) 157
(82.2%)
0.754 ns 1.094
(0.625-
1.914)
84 (85.7%) 66(86.8%) 0.831 ns 1.1
(0.46-
2.634)
rs1882409
(A/G)
Intron1 X
A 69(29.0%) 82(30.7%) 0.673 ns 1.086
(0.741-
1.591)
42 (30.0%) 59(30.9%) 0.862 ns 1.043
(0.649-
1.676)
27(27.6%) 23(30.3%) 0.695 ns 1.141
(0.590-
2.208)
rs5916352
(G/C)
Intron1 X
C 184(77.0%) 215
(81.7%)
0.187 ns 1.339
(0.867-
2.067)
34 (24.1%) 32(17.1%) 0.117 ns 0.65
(0.378-
1.117)
21 (21.4%) 16(21.1%) 0.952 ns 1.023
(0.492-
2.128)
Assoc Allele, associated allele; OR, odds ratio; 95%CI, 95% confidence interval; Pcorr value, corrected by Bonferroni’s approach for multiple testing, ns, not significant. Male samples (n = 333) include 191 cases and 142
controls, female samples (n = 87) include 38 cases and 49 controls. Significant P-values are indicated in bold.
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0even though the haplotype X
G-X
G was significantly more
frequent in controls compared to patients with ASDs in
female subgroup (P = 0.024, OR = 0.404, 95%CI: 0.18-
0.904). In addition, another two-marker haplotype block
(rs1882409-rs5916352) was identified in male subgroup
showing significant difference between patients with ASDs
and controls (global P = 0.035), and haplotype X
A-X
C was
significantly more frequent in male ASDs compared to
male controls (P = 0.023, OR = 2.546, 95%CI: 1.112-
5.832), while the difference disappeared after permutation
test.
Power analysis
We estimated the statistical power using the G*Power
program, based on the method of asymptotic noncentral-
ity parameters for case-control association studies. Post-
hoc power analysis showed that the used sample size had
a 53.6% power to detect a small gene effect (correspond-
i n gt o0 . 1 )a n da9 9 . 9 %p o w e rt od e t e c tam e d i u mg e n e
effect (corresponding to 0.3) of the allele frequencies of
SNP rs4844285 for a significant association at the alpha
level of 0.05. Of the haplotype frequencies of
rs11795613-rs4844285-rs4844286, the used sample size
had a 37.5% power to detect a small gene effect (corre-
sponding to 0.1) and a 99.9% power to detect a medium
gene effect (corresponding to 0.3) at the alpha level of
0.05 (data not shown).
Discussion
Our present results do lend support for the hypothesis
that a common variant in the NLGN3 gene (SNP
rs4844285) may influence the susceptibility for male
A S D s .T oo u rk n o w l e d g e ,t h i sc a n d i d a t eg e n es t u d y
represents a focus association study of common variants
of neuroligin genes in etioloty of ASDs, although pre-
vious studies have provide evidence of rare mutations of
NLGN3 and NLGN4X genes causing to ASDs. Using a
relative homogenous samples and a case-control based
design, we found that an intronic SNP rs4844285 in
NLGN3 gene and a specific 3-marker haplotype block
(rs11795613-rs4844285-rs4844286) were associated with
ASDs and showed a male bias after multiple correction,
Figure 1 LD of the SNPs of NLGN3 and NLGN4X genes. The LD value (D’ and r
2) within each diamond was computed using Haploview. The
dark gray diamonds indicate strong evidence of LD for no historical recombination, while the white diamonds indicate strong evidence of LD.
The confidence bound values of the light gray diamonds are between the valves reflected in the dark and white diamonds. Haplotype blocks by
the Gabriel method are shown also. A: LD of the SNPs of NLGN3 gene with D’ and r
2 values for males, B: LD of the SNPs of NLGN3 gene with D’
and r
2 values for females, C: LD of the SNPs of NLGN4X gene with D’ and r
2 values for males, D: LD of the SNPs of NLGN4X gene with D’ and r
2
values for females.
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rate of ASDs in males is higher than that in females.
Simultaneously, further evidence was obtained for the
fact that these known rare mutations in NLGN3 and
NLGN4X genes may be not enriched in subjects with
ASDs in Chinese Han cohort.
The neuroligin 3 gene (NLGN3) and neuroligin 4X
gene (NLGN4X), localized on Xq13.1 and Xp22.33,
encode a member of a family of neuronal cell surface
proteins serving as splice site specific ligands for neurex-
ins and may be involved in the formation, organization
and remodeling of central nervous system synapses. The
encoded proteins were localized postsynaptically and
were shown to be sufficient to trigger the formation of
new presynaptic architecture and induce the functional
presynaptic differentiation in vitro [39]. So, it was specu-
lated that genetic variants in these neuroligin genes may
be associated with neurodevelopmental disorders, such
as autism and Asperger syndrome, with a combination
of rare variants having a dramatic effect in fewer indivi-
duals and common variants having small increments of
risk in majority individuals. To date, only rare variants
of these two neuroligin genes have been soundly estab-
lished risk for ASDs responsible for a small fraction of
events, while no common variant was available for sus-
ceptible to ASDs. For this reason, it is the most
Table 3 Haplotype blocks frequencies and case-control association analysis with ASDs within the NLGN3 and NLGN4X
genes
Gene Samples Haplotype
Sequence
Freqency in
controls
Freqency in
cases
Global P
value
c
2 Individual P
value
Pper
value
OR (95%CI)
NLGN3 Males Block1: rs11795613-rs4844285-rs4844286
X
A-X
G-X
T 0.579 0.716 0.032 6.74 0.009 0.017 1.834
(1.158-
2.907)
X
G-X
A-X
G 0.321 0.226 3.729 0.053 0.098 0.618
(0.378-1.009)
X
G-X
A-X
T 0.079 0.042 1.975 0.160 0.462 0.515
(0.202-1.317)
Females Block 1: rs11795613-rs4844285
X
A-X
G 0.673 0.816 0.035 4.458 0.035 0.08 2.147
(1.048-
4.400)
X
G-X
A 0.327 0.184 4.458 0.035 0.08 0.446
(0.227-
0.954)
Block 2: rs4844286-rs5981079
X
T-X
T 0.557 0.678 0.221 2.573 0.109 0.244 1.671
(0.895-3.121)
X
G-X
C 0.306 0.197 2.64 0.104 0.242 0.557
(0.274-1.133)
X
T-X
C 0.137 0.125 0.044 0.834 0.996 0.902
(0.370-2.199)
NLGN4X Males Block 2: rs1882409-rs5916352
X
G-X
C 0.700 0.695 0.035 0.009 0.925 1 0.977
(0.607-1.575)
X
A-X
G 0.243 0.171 2.557 0.110 0.244 0.644
(0.374-1.107)
X
A-X
C 0.057 0.134 5.17 0.023 0.068 2.546
(1.112-
5.832)
Females Block 1**: rs6529901-rs5916397
X
A-X
A 0.514 0.595 0.145 1.122 0.290 0.665 1.386
(0.756-2.539)
X
G-X
A 0.200 0.247 0.557 0.456 0.831 1.315
(0.641-2.697)
X
G-X
G 0.269 0.129 5.083 0.024 0.060 0.404
(0.180-
0.904)
OR, odds ratio; 95%CI, 95% confidence interval. Pper value, p value with 10,000 times permutation test. The haplotypes with frequencies lower than 5% excluded
from analysis. Block 1**, the two SNP, rs6529901 and rs5916397, was in relatively high LD with D’ > 0.8 and regarded as a block for multiple-marker analysis in
this study. Significant p-values are indicated in bold.
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variant in the NLGN3 gene was identified to be strongly
associated with susceptibility to male ASDs. The
NLGN3 gene is composed of eight exons with the start
codon in exon2 [40] and the SNP rs4844285 implicated
was an intronic common variant localizing in the intron
2o ft h eNLGN3 gene with unknown function. Our
result showed that this SNP appeared to be most pro-
nounced associated with an increased risk for ASDs
among affected males after multiple testing corrections
(Pcorr = 0.048), with rs4844285-X
G as risk allele (OR =
1.872, 95%CI:1.175-2.981). The finding was further sup-
ported by the multimarker analysis, which also showed,
in male subjects, one three-marker haplotype block
(rs11795613-rs4844185-rs4844286) containing this indi-
vidual SNP was vulnerable to ASDs (global P value =
0.032) and the most frequent haplotype X
A-X
G-X
T was
susceptible (P = 0.009, OR = 1.834, 95% CI: 1.158-
2.907). However, how this specific intron relates to
A S D sm a yb ep o s s i b l et h a tt h i si n t r o n i cS N Pd on o t
change gene function and a yet unidentified causal SNP
may be linked to this haplotype and/or lies within or
very close to the region spanning rs11795613 and
4844286, or a possibility of this intronic SNP playing
pivotal roles in gene regulation. In addition, although
nominally significant differences were detected for this
SNP among female samples both in single SNP and hap-
lotype analysis, the differences did not survive multiple
testing corrections. The similar finding was obtained
from another SNP rs5916397 of NLGN4X gene in
female subjects, which showed nominal significant dif-
ference in allelic frequencies and haplotype X
G-X
G
(rs6529901-rs5916397) between the female ASDs and
controls (allelic: p = 0.047, Haplotype X
G-X
G:p=
0.024), while this results disappeared for multiple cor-
rection. It was implicated that these SNPs may not
make a statistically significant contribution to ASDs sus-
ceptibility in our female samples.
It was of particular meaningful that our result of associa-
tion of SNP rs4844285 in NLGN3 gene with ASDs exhib-
ited a male bias. Because of the overrepresentation of
males in samples with ASDs, as well as evidence for sex-
specific effects on X chromosome, we hypothesized that
stratifying by gender may reduce genetic heterogeneity at
these two X-linked neuroligin loci. One possible explana-
tion of sex-specific association is that the underlying
genetic modulators for ASDs may differ with gender.
Indeed, a large body of researches have accumulated evi-
dences that male and female brains develop differently not
only in function field, but also that this sexual dichotomy
extends to the macroscopic structures of the brain. There-
for, genes located on the X chromosome and those genes
directly related to the function of sex-related hormones
are clear candidates. There is also increasing evidence that
differentially regulated genes on the autosomes are inte-
grally involved in normal sex-specific brain development
[41-43]. Evidences from multiple studies which have iden-
tified a major male-specific linkage peak at chromosome
17q11 [44,45]. Although to what extent these regulatory
effects may ultimately relate to normal male and female
brain development remains unclear, it is obvious that
there are substantial differences between the sexes at the
molecular level. So, it is possible that NLGN3 may be cau-
sative gene for male predominance of ASDs. Another pos-
sible explanation is that the power to detect the observed
difference reduces due to the small sample size of females
in our present study. So, our sex-specific analyses were
exploratory and require co n f i r m a t i o ni na d d i t i o n a l
samples.
Several notions of this study should be considered for
this association. First, the tagging SNPs analyzed were
unable to comprehensively cover the common variants
across the both genes and other SNPs which were not
selected in our present study may be associated with
ASDs, further analysis on the basis of detailed SNPs cov-
erage of these genes are necessary. In addition, all of the
SNPs investigated in the present study exist in introns
with unknown function and could not be regarded to be
causally related to ASDs but rather is likely to be in link-
age disequilibrium with an as yet untested, functional
variant. Second, there were different haplotype blocks
g e n e r a t e db e t w e e nt h em a l ea n df e m a l eg r o u pb yt h e
default algorithm of Gabriel method due to small differ-
ence of LD (D’ and r
2 value) between pair-wise SNPs for
different gender. Third, the Bonferroni correction was
used for multimarker testing in our present study. It
would be overly conservative for non-independent tests.
Fourth, the average age of subjects was not well matched
between the controls and ASDs in the present study.
However, this should not be regarded to have a marked
affect on the results, since genetic nature of SNP is gen-
erally unlikely to change with age.
Apart from this, rare genetic variants of susceptible
genes are being increasingly discoveried as etiological fac-
tors in ASDs. But most instances, rare mutations of
NLGN3 and NLGN4X genes have not yet been widely
replicated and systemically validated by other indepen-
dent studies within different population. Seeking replica-
tion in other ASDs samples is important to confirm the
causative nature of these mutations and to determine
their frequency. In our present study, we sought to repli-
cate the 7 known rare variants associated with ASDs in
both genes from Chinese Han population and revealed
no mutations or rare variants. This lack of replication of
rare variants of these two genes in our samples may be
due to greater heterogeneity across different ethnic popu-
lation, and highlights the fact that these known rare
mutations may be not enriched in patients with ASDs in
Yu et al. Behavioral and Brain Functions 2011, 7:13
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Page 8 of 10Chinese Han cohort. Moreover, it is important to note
that, by current study design, sequencing analysis was
not conducted and we could have missed other rare
mutations potentially responsible for ASDs within these
genes in our samples, such as those found in previous
studies or likely to be de novo. Additional screening of
much larger numbers of ASDs individuals from different
ethnic backgrounds is needed to determine to what
degree these genes are involved in the etiology of ASDs.
In summary, the present study provide initial evidence
that common variants in NLGN3 gene may play a role
in the etiology of ASDs among affected males in Chi-
nese Han population, and further support the hypothesis
that defect of synapse might involvement in the patho-
physiology of ASDs. Our results of sex-specific associa-
tion need replication and confirmation in independent
samples. The molecular mechanisms of synaptic genes
and X-linked genes remain excellent candidates for
further genetic investigations responsible for etiology of
ASDs.
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